Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea · Delayed Price · Currency is KRW 82,300
+900 (1.11%)
At close: Oct 2, 2025
KRX:185750 Market Cap
KRX:185750 has a market cap or net worth of 1.08 trillion as of October 6, 2025. Its market cap has decreased by -28.91% in one year.
Market Cap
1.08T
Enterprise Value
1.07T
Revenue
1.66T
Ranking
n/a
PE Ratio
17.71
Stock Price
82,300.00
Market Cap Chart
Since December 6, 2013, KRX:185750's market cap has increased from 677.45B to 1.08T, an increase of 59.29%. That is a compound annual growth rate of 4.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 1,079.12B | -8.47% |
| Dec 30, 2024 | 1,178.98B | -29.22% |
| Dec 28, 2023 | 1,665.71B | 66.27% |
| Dec 29, 2022 | 1,001.82B | -23.66% |
| Dec 30, 2021 | 1,312.27B | -49.00% |
| Dec 30, 2020 | 2,572.97B | 145.08% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |